Global Prefilled Syringes Market Research Report – Forecast to 2024

$4,450$6,250

Global Prefilled Syringes Market Research Report By Material (Glass Prefilled Syringes(Oil siliconisedsyringes and Baked on silicone syringes) and Plastic Syringes), By Type(Conventional Prefilled Syringes and Safety Prefilled Syringes), By Design (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes and Customized Prefilled Syringes), By End-User (Hospitals/Clinics, Ambulatory Surgical Center and Others), By Region – Forecast to 2024

Clear

Description

Introduction
Prefilled syringes are disposable syringes that are already loaded with the substance that needs to be injected. A prefilled syringe contains a single dose of medication to which a needle has been fixed by the manufacturer. Parenteral delivery being the second most applied route of drug delivery after oral drug administration has led to a demand for advanced parenteral drug-delivery systems that offer convenience and ease of administration. Prefilled syringes have gained acceptance especially for chronic conditions that require repeated administration of drugs. Its ability to ensure the right dosage, ease of administration, and reduced risk of contamination are driving market growth.
Factors such as the high prevalence of chronic diseases and technological advancements in the medical devices industry are expected to fuel the demand for prefilled syringes. The growing number of diabetic patients is also propelling the growth of the market. However, product recalls and stringent regulations are the major challenges for market players.
The global market for prefilled syringes has been segmented on the basis of material, type, design, end user, and region. On the basis the material of type, the market has been divided into glass prefilled syringes and plastic syringes. The glass prefilled syringes segment has been further classified as oil siliconized syringes and baked-on silicone syringes.
On the basis of type, the global prefilled syringes market has been segmented into conventional prefilled syringes and safety prefilled syringes. By design, the market has been categorized as single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes.
Based on end user, the market has been divided into hospitals/clinics and ambulatory surgical centers.
The global prefilled syringes market accounted for USD 3493.99 million in 2015 and is expected to register a CAGR of 10.20% during the forecast period.
Key Players
Some of the key players in the global prefilled syringes market are Gerresheimer AG, Schott AG,Medtronic, Terumo Corporation, Abbott, Nipro Corporation, Baxter, Becton, Dickinson and Company, West Pharmaceutical, Weigao Group, Vetter Pharma International GmbH, and OMPI (A Stevanato Group Company).
Study objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global prefilled syringes market
• To provide insights into factors influencing and affecting market growth
• To provide historical, current, and forecast revenue of market segments based on material, type, design, and end user
• To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
• To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
• To provide economic factors, technology trends, and market trends that influence the global prefilled syringes market

Target Audience
• Medical Devices Companies
• Pharmaceutical and Biotechnology Companies
• Research and Development Companies
• Government Research Institutes
• Academic Institutes and Universities

Key Findings
• The global prefilled syringes market is expected to reach a value of USD 8397.23 million by 2024 at a CAGR of 10.20%.
• On the basis of material, the glass prefilled syringe segment is projected to be larger, registering a CAGR of 9.98% during the forecast period.
• On the basis of type, the conventional prefilled syringes segment is expected to account for the largest market share of 10.09% from 2018 to 2024.
• The single-chamber prefilled syringes design segment is projected to exhibit a CAGR of 10.42% during the assessment period.
• By end user, the hospitals and clinics segment is expected to be larger to be valued at USD 4619.73 million by 2024.
• On the basis of region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The European market is expected to be the largest at an estimated value of USD 3382.86 million by 2024.
• Asia-Pacific is projected to be the fastest-growing market at a CAGR of 10.78% from 2018 to 2024.
The report also offers a regional analysis.
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o South Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Table of Contents

Table of Contents:

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objectives
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 High Prevalence of Chronic Diseases
4.2.2 Technological Advancements
4.3 Restraints
4.3.1 Product Recalls
4.4 Challenge
4.4.1 Stringent Regulations
4.5 Mega Trend
4.5.1 Technological Trends
4.6 Macroeconomics
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 R&D
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Monitoring
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
6 Global Prefilled Syringes Market, by Material
6.1 Introduction
6.2 Glass Prefilled Syringes
6.2.1 Oil-Siliconized Syringes
6.2.2 Baked-On Silicone Syringes
6.3 Plastic Syringes
7 Global Prefilled Syringes Market, by Type
7.1 Introduction
7.2 Conventional Prefilled Syringes
7.3 Safety Prefilled Syringes
8 Global Prefilled Syringes Market, by Design
8.1 Introduction
8.2 Single-Chamber Prefilled Syringes
8.3 Dual-Chamber Prefilled Syringes
8.4 Customized Prefilled Syringes
9 Global Prefilled Syringes Market, by End User
9.1 Introduction
9.2 Hospitals/Clinics
9.3 Ambulatory Surgical Centers
10 Global Prefilled Syringes, by Region
10.1 Introduction
10.2 Europe
10.2.1 Western Europe
10.2.1.1 Germany
10.2.1.2 France
10.2.1.3 UK
10.2.1.4 Italy
10.2.1.5 Spain
10.2.1.6 Rest of Western Europe
10.2.2 Eastern Europe
10.3 Americas
10.3.1 North America
10.3.1.1 US
10.3.1.2 Canada
10.3.2 South America
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Introduction
12 Company Profiles
12.1 Gerresheimer AG
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products Offering
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Schott AG
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offering
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 Medtronic
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products Offering
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 Terumo Corporation
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products Offering
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 Abbott
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offering
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Nipro Corporation
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offering
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Baxter
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products Offering
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 Becton, Dickinson and Company
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offering
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 West Pharmaceutical
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offering
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Weigao Group
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offering
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
12.11 Vetter Pharma International GmbH
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products Offering
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategy
12.12 OMPI (A Stevanato Group Company)
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Products Offering
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategy
13 Conclusion
13.1 Key Findings
13.1.1 CEO’s Viewpoint
13.1.2 Unmet Needs
13.1.3 Key Companies to Watch
13.1.4 Prediction for the Prefilled Syringes Industry
14 Appendix
14.1 Discussion Blueprint
14.2 Recent Key Developments
14.3 References

Additional information

Publisher

Geography Covered

Date Published

Pages

Format